Browse current and previous editions of Switzer Report
It is a very esoteric niche on the ASX, but regenerative medicine is a fascinating area. ASX-listed companies PolyNovo, AVITA Medical and AROA Biosurgery all focus on regenerative medicine and soft-tissue repair, targeting severe burns, trauma and complex wounds, using active biological or structural reconstruction.
Nine upgrades and seventeen downgrades. For the week ending Friday, 14 August 2026 – the second week of the August reporting season – the seven brokers monitored by FNArena issued nine ratings upgrades and seventeen downgrades.
Every stock Ryan Stokes, Lauren Antonoff, Julia Lee, Michael Gable and Mark Wallace discussed on this week's Switzer Show, in their own words.
It's a reporting season special on the Switzer Show this week, with two CEOs defending their numbers and two market watchers deciding what to do with them.
US stocks overall are heading for the third winning week in a row, and you can thank the spectacular earnings reports of most companies that have been on 'show-and-tell' over the past three weeks. Given the prevailing concerns about the future because of Iran's impact on oil prices, inflation and interest rates, the fact that FactSet reports that more than 90% of S&P 500 companies have posted second-quarter results, and earnings growth from the year-earlier period is tracking around 50%.
Beaten-down property trusts offer attractive yields and valuations after years of pain, but the road back to favour could still be a long one.
Peter Switzer and Paul Rickard take your questions live, and this week the viewer picks set the agenda:
Is Perth shipbuilder Austal (ASB) being taken over? Why is Suncorp (SUN) paying a fully franked special dividend of 10c per share? What do the brokers think of location sharing app company Life360 which got smashed after its result on Tuesday? Does CBA offer a dividend re-investment plan, and if so, how do I tell them I want to participate?
Michael Gable, Managing Director of Fairmont Equities, says mining giant BHP (BHP) is breaking out to new highs and providing a fresh buying opportunity ahead of its full year results on 18 August.
The healthcare sector has had a tough 12 months. But there are signs the worst may be over, and Resmed’s strong quarterly result is one […]
While flying home from London, I looked back at last week’s Switzer Report to see how our experts’ calls performed. The short answer: very well […]
For the week ending Friday 7 August 2026, the first week of the August reporting season, the seven stockbrokers monitored daily by FNArena issued two […]
I went looking for ASX companies that are genuine disruptors trading at attractive prices. I found two global software stars taking on decades-old legacy systems […]
For our “HOT” stock today, Raymond Chan, Private Client Adviser and Head of Asian Desk at Morgans, explains why Morgans’ stock of the week is […]
Cathie shares her 2026 predictions on the AI companies and technologies she believes will boom over the next five years. Peter and Cathie also discuss […]
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.